Overview of the patients with FL included in this study
| . | No-HT (n = 184) . | pre-HT (n = 25) . | Overall (n = 209) . |
|---|---|---|---|
| Age, y | |||
| Mean (SD) | 59.8 (11.5) | 60.0 (13.2) | 59.8 (11.7) |
| Median (min, max) | 61.0 (33.0, 86.0) | 58.0 (36.0, 84.0) | 61.0 (33.0, 86.0) |
| Sex | |||
| Female | 91 (49.5%) | 11 (44.0%) | 102 (48.8%) |
| Male | 93 (50.5%) | 14 (56.0%) | 107 (51.2%) |
| FLIPI score | |||
| High | 33 (17.9%) | 6 (24.0%) | 39 (18.7%) |
| Low/intermediate | 62 (33.7%) | 7 (28.0%) | 69 (33.0%) |
| Missing | 89 (48.4%) | 12 (48.0%) | 101 (48.3%) |
| Grade | |||
| 1/2 | 174 (94.6%) | 19 (76.0%) | 193 (92.3%) |
| 3A | 9 (4.8%) | 6 (24.0%) | 15 (7.2%) |
| Missing | 1 (0.5%) | 0 (0%) | 1 (0.5%) |
| BCL2 translocated | |||
| Yes | 158 (85.9%) | 20 (80.0%) | 178 (85.2%) |
| No | 26 (14.1%) | 5 (20.0%) | 31 (14.8%) |
| LDH ratio | |||
| Mean (SD) | 0.835 (0.270) | 1.13 (0.693) | 0.883 (0.383) |
| Median (min, max) | 0.759 (0.470, 1.86) | 0.945 (0.573, 3.24) | 0.791 (0.470, 3.24) |
| Missing | 85 (46.2%) | 6 (24.0%) | 91 (43.5%) |
| Overall survival, y | |||
| Mean (SD) | 5.94 (4.36) | 9.37 (6.42) | 6.35 (4.77) |
| Median (min, max) | 5.29 (0.0960, 24.1) | 8.53 (0.680, 21.4) | 5.38 (0.0960, 24.1) |
| Progression-free survival, y | |||
| Mean (SD) | 3.13 (4.44) | 2.25 (2.09) | 3.03 (4.24) |
| Median (min, max) | 0.755 (0, 22.2) | 1.17 (0.390, 7.65) | 0.920 (0, 22.2) |
| . | No-HT (n = 184) . | pre-HT (n = 25) . | Overall (n = 209) . |
|---|---|---|---|
| Age, y | |||
| Mean (SD) | 59.8 (11.5) | 60.0 (13.2) | 59.8 (11.7) |
| Median (min, max) | 61.0 (33.0, 86.0) | 58.0 (36.0, 84.0) | 61.0 (33.0, 86.0) |
| Sex | |||
| Female | 91 (49.5%) | 11 (44.0%) | 102 (48.8%) |
| Male | 93 (50.5%) | 14 (56.0%) | 107 (51.2%) |
| FLIPI score | |||
| High | 33 (17.9%) | 6 (24.0%) | 39 (18.7%) |
| Low/intermediate | 62 (33.7%) | 7 (28.0%) | 69 (33.0%) |
| Missing | 89 (48.4%) | 12 (48.0%) | 101 (48.3%) |
| Grade | |||
| 1/2 | 174 (94.6%) | 19 (76.0%) | 193 (92.3%) |
| 3A | 9 (4.8%) | 6 (24.0%) | 15 (7.2%) |
| Missing | 1 (0.5%) | 0 (0%) | 1 (0.5%) |
| BCL2 translocated | |||
| Yes | 158 (85.9%) | 20 (80.0%) | 178 (85.2%) |
| No | 26 (14.1%) | 5 (20.0%) | 31 (14.8%) |
| LDH ratio | |||
| Mean (SD) | 0.835 (0.270) | 1.13 (0.693) | 0.883 (0.383) |
| Median (min, max) | 0.759 (0.470, 1.86) | 0.945 (0.573, 3.24) | 0.791 (0.470, 3.24) |
| Missing | 85 (46.2%) | 6 (24.0%) | 91 (43.5%) |
| Overall survival, y | |||
| Mean (SD) | 5.94 (4.36) | 9.37 (6.42) | 6.35 (4.77) |
| Median (min, max) | 5.29 (0.0960, 24.1) | 8.53 (0.680, 21.4) | 5.38 (0.0960, 24.1) |
| Progression-free survival, y | |||
| Mean (SD) | 3.13 (4.44) | 2.25 (2.09) | 3.03 (4.24) |
| Median (min, max) | 0.755 (0, 22.2) | 1.17 (0.390, 7.65) | 0.920 (0, 22.2) |
LDH, lactate dehydrogenase; max, maximum; min, minimum; SD, standard deviation.